News

AddToAny

Google+ Facebook Twitter Twitter

Histopathology qualification funding

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

The IBMS has announced new funding support for Institute members undertaking IBMS/RCPath histopathology qualifications.

The funding will have a direct and positive impact on IBMS members who are currently enrolled, or about to enrol, via the pathology network route, to undertake our exams programme.

It also demonstrates a tremendous mark of confidence in the Institute’s professional examinations and underlines their value in the training of scientists to undertake advanced and consultant roles.

IBMS President, Allan Wilson, said: “This funding initiative is fantastic news for both scientists and patients moving forward.

“Histopathology laboratories have been under considerable pressure as demand for services increases.

“The funding will not only help to allay these pressures and give members the opportunity to undertake these new advanced roles, but also allow patients to reap the benefits of new developments in diagnostics, monitoring and therapy in cancer, assisting in future-proofing NHS cancer services.”  

For more information, visit bit.ly/2VEbzjv

Image Credit | iStock

Related Articles

IBMS podcast relaunched

The IBMS Biopod has been revamped, renamed and relaunched as IBMSpod.

Reporting in histopathology: some personal insights

The team at Leicester Royal Infirmary have collaborated on this article, which discusses their experiences of scientist reporting in histopathology.

"Don't delay cancer treatment"

A European Society for Medical Oncology (ESMO) interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published.

"AI research could pose risk for patients"

Many studies claiming that artificial intelligence (AI) is as good as, or better than, human experts at interpreting medical images are of poor quality and potentially exaggerated.

Top